Graft-Versus-Host Transplant Immunology

First Things First (assess & treat for the following)

  • 50% of allogeneic BMT patients develop acute or chronic graft versus host disease (GVHD) of variable severity.
  • GVHD = donor’s bone marrow attacks the patient’s organs and tissues, leading to organ dysfunction and a worsened immunocompromised state
  • Acute GVHD usually develops < 100 days after allogeneic BMT.
  • Chronic GVHD usually develops >100 days after allogeneic BMT.
  • The incidence of both types of GVHD increases with patient age.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: April 28, 2010